Who is sponsoring NCT04178707?

NCT04178707 is sponsored by University Hospital, Umeå.

What drugs are being tested in NCT04178707?

Interventions in NCT04178707: OnZurf Probe, Senzime AB, Uppsala, Sweden.

What condition does NCT04178707 study?

NCT04178707 studies Anal Fistula.

Is NCT04178707 still recruiting?

NCT04178707 is currently status unknown. Last updated 13 December 2022.

Last reviewed 2022-12-13 · How we verify

NCT04178707

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anal Fistula and Microdialysis - What is Yet to Learn?

Status unknown NA Last updated 13 December 2022

What this trial tests

NA trial testing OnZurf Probe, Senzime AB, Uppsala, Sweden in Anal Fistula in 20 participants. Status unknown.

Timeline

10 December 2019

Primary endpoint
30 November 2023

20 December 2024

Quick facts

Lead sponsor	University Hospital, Umeå
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	20
Start date	10 December 2019
Primary completion	30 November 2023
Estimated completion	20 December 2024
Sites	1 location across Sweden

Drugs / interventions tested

OnZurf Probe, Senzime AB, Uppsala, Sweden

Conditions studied

Anal Fistula — all drugs for Anal Fistula →

Sponsor

University Hospital, Umeå

Who can join

18 and older, any sex, with Anal Fistula. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anal Fistula can be a challenging condition to treat. Microdialysis has never before been used to examine the inner environment of anal fistula. This is now going to be performed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anal Fistula

Currently open trials in the same condition.

NCT07477496 — Recurrence and Anal Fistula Patient Reported Outcomes Trial · recruiting
NCT07081373 — Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients. · NA · recruiting
NCT06803550 — Effect of Enhanced Recovery After Surgery for Benign Anorectal Conditions · NA · recruiting
NCT06303752 — Tissue Therapy of Transsphincteric Anal Fistula · Phase 1, PHASE2 · recruiting
NCT05641844 — A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04178707 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Umeå
Last refreshed: 13 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04178707.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing